Delivery Order HHSN272201300002I-HHSN27200001

Ended Awarded Last action

Contract number
HHSN27200001
Awardee
Awarding agency
Obligated
$3,605,431

Award facts

Opportunity
  • NIAIDDAIDSNIHAI2012138 Solicitation number
Contract value 100% obligated
$3,605,430.51 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 6 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00017 -$75,554
Funding Only Action P00016 $14,273
Funding Only Action P00015 $80,632
Funding Only Action P00014 -$3,757
Funding Only Action P00013 -$1,367
Other Administrative Action P00012 $0
Other Administrative Action P00011 $0
Funding Only Action P00010 -$40,997
Exercise an Option P00009 $566,053
Exercise an Option 8 $549,675
Funding Only Action 7 -$2,436
Other Administrative Action 6 $0
Exercise an Option 5 $533,784
Exercise an Option 4 $518,332
Exercise an Option 3 $503,347
Exercise an Option 2 $488,790
Other Administrative Action 1 $0
Original award Simian vaccine evaluation units $474,656
Show all 18

About this award

Written by GovTribe AI ·

This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL) for the "Simian Vaccine Evaluation Units" program. The $3,605,430.51 cost-plus-fixed-fee contract does not have a set-aside designation and runs through September 9, 2023. It is part of a larger Simian Vaccine Evaluation Units 2013-2020 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. ABL, a foreign-owned for-profit manufacturer, provides a broad range of preclinical development and manufacturing services to NIAID, including assays, sample logistics, biosafety containment, and non-human primate studies for vaccines and other infectious disease countermeasures. The company has been awarded multiple IDIQ contracts by NIAID to support its vaccine and therapeutic development programs.

Quick answers

Who was awarded contract HHSN27200001?

HHSN27200001 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 1, 2013.

How much is contract HHSN27200001 worth?

The government has obligated $3,605,431 on HHSN27200001.

Is contract HHSN27200001 an order under another contract?

Yes. HHSN27200001 is a delivery order under HHSN272201300002I, an indefinite delivery contract, on Simian Vaccine Evaluation Units 2013-2020.

Was contract HHSN27200001 competed?

The extent of competition for HHSN27200001 was full and open competition. The government received 6 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login